Clinical Trials Browser

Phase 3 × Hormone Receptor Positive HER-2 Negative Breast Cancer × Docetaxel × Clear all

NCT05901428 2023-06-15

TCb vs EC-T in High Risk ER+/HER2- Breast Cancer

Phase 3 Recruiting

Hormone Receptor Positive HER-2 Negative Breast Cancer